俄罗斯B组链球菌毒力岛PAI-A和PAI-A1的流行率

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

组链球菌B或Streptococcus agalactiae是新生儿和成人严重疾病的病原体。组链球菌B的移动遗传元件中发现了分别含有sspB1sspB1a基因的致病岛PAI-A和PAI-A1。SspB基因的存在与泌尿生殖道感染相关。本研究的目的是确定与来自圣彼得堡的菌株相比,在莫斯科流通的具有致病性岛PAI-A和PAI-A1的组链球菌菌株B的出现频率。莫斯科菌株的基因组中未检测到sspB1基因以及PAI-A致病岛。临床菌株基因组中sspB1a基因和PAI-A1致病岛的出现频率是定植菌株基因组的3倍。因此,可以假设sspB家族的基因更具有定植孕妇和新生儿的B组链球菌的特征。

作者简介

Evgenia Kuleshevich

Institute of Experimental Medicine

Email: k-zh-v@mail.ru
ORCID iD: 0000-0002-3180-6491

Cand. Sci. (Biol.)

俄罗斯联邦, Saint Petersburg

Yury Ilyasov

Institute of Experimental Medicine

Email: kolpino@hotmail.com
SPIN 代码: 2204-1677
俄罗斯联邦, Saint Petersburg

Dmitry Linnik

Institute of Experimental Medicine

Email: linnikdm@yandex.ru
ORCID iD: 0000-0002-8046-9743
俄罗斯联邦, Saint Petersburg

Anastasia Malchenkova

Institute of Experimental Medicine

Email: nastya.malchenkova@yandex.ru
ORCID iD: 0000-0003-2201-0472
SPIN 代码: 8957-5056
俄罗斯联邦, Saint Petersburg

Olga Arzhanova

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott,
Saint Petersburg State University

Email: arjanova_olga@mail.ru
ORCID iD: 0000-0003-3059-9811

MD, Dr. Sci. (Med.), Professor, Honored Doctor of the Russian Federation, Leading Researcher. The Department of Obstetrics and Perinatology; Professor. The Department of Obstetrics, Gynecology, and Reproductive Sciences, Medical Faculty

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034; 7-9 Universitetskaya emb., St. Petersburg, 199034

Nikolay Briko

I.M. Sechenov First Moscow State Medical University

Email: nbrico@mail.ru
ORCID iD: 0000-0002-6446-2744
SPIN 代码: 2992-6915

MD, Dr. Sci. (Med.), Professor, Honored Scientist of the Russian Federation, Academician of the Russian Academy of Sciences

俄罗斯联邦, 8-2 Trubetskaya str., Moscow, 119991

Ekaterina Glushkova

I.M. Sechenov First Moscow State Medical University

Email: ekaterina-1801@mail.ru
ORCID iD: 0000-0001-6997-7598
SPIN 代码: 2336-3176

MD, Cand. Sci. (Med.)

俄罗斯联邦, 8-2 Trubetskaya str., Moscow, 119991

Tatyana Priputnevich

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov

Email: priput1@gmail.com
ORCID iD: 0000-0002-4126-9730
SPIN 代码: 8383-7023

MD, Dr. Sci. (Med.)

俄罗斯联邦, 4 Street Akademika Oparina, Moscow, 117997

Alexander Suvorov

Institute of Experimental Medicine; Saint Petersburg State University

编辑信件的主要联系方式.
Email: alexander_suvorov1@hotmail.com
ORCID iD: 0000-0003-2312-5589
SPIN 代码: 8062-5281

MD, Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences

俄罗斯联邦, Saint Petersburg; Saint Petersburg

参考

  1. Totolyan AA, Suvorov AN, Dmitriev AV. Streptokokki gruppy V v patologii cheloveka. Saint Petersburg: Chelovek; 2009. (In Russ.)
  2. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–556. doi: 10.1016/S0140-6736(11)61651-6
  3. Vasilyeva VA, Shipitsyna EV, Shalepo KV, et al. Molecular epidemiology of infections caused by group B streptococcus in pregnant women and newborns, and development of preventive vaccines. Journal of Obstetrics and Women’s Diseases. 2018;67(5):62–73. (In Russ.). doi: 10.17816/JOWD67562-73
  4. Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018;9:437. doi: 10.3389/fmicb.2018.00437
  5. Madrid L, Seale AC, Kohli-Lynch M, et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(Suppl 2):S160–S172. doi: 10.1093/cid/cix656
  6. Song JY, Lim JH, Lim S, et al. Progress toward a group B streptococcal vaccine. Hum Vaccin Immunother. 2018;14(11):2669–2681. doi: 10.1080/21645515.2018.1493326
  7. Lindahl G, Stålhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev. 2005;18(1):102–127. doi: 10.1128/CMR.18.1.102-127.2005
  8. Suvorov AN, Grabovskaya KB, Leontyeva GF, et al. Recombinant fragments of conservative proteins of group B Streptococci as a basis of specific vaccine. Zhurnal mikrobiologii, èpidemiologii i immunobiologiiZhurnal mikrobiologii, èpidemiologii i immunobiologii. 2010;2:44–50. (In Russ.)
  9. Chmouryguina I, Suvorov A, Ferrieri P, Cleary PP. Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun. 1996;64(7):2387–2390. doi: 10.1128/IAI.64.7.2387-2390.1996
  10. Cleary PP, Handley J, Suvorov AN, et al. Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun. 1992;60(10):4239–4244. doi: 10.1128/IAI.60.10.4239-4244.1992
  11. Rajagopal L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 2009;4(2):201–221. doi: 10.2217/17460913.4.2.201
  12. Suvorov A, Grabovskaja K, Savicheva A, et al. Determination of group B streptococcal genes encoding putative adherence factors in GBS clinical strains. Streptococci – New Insights Into an Old Enemy. 2006;1289:227–230. doi: 10.1016/j.ics.2005.11.026
  13. Oganyan KA, Suvorov AN, Zaciorskaya SL, et al. The course and outcomes of pregnancy in women with urogenital tract colonization witgroup B streptococcus inclusive genes of sspB family. Journal of Obstetrics and Women’s Diseases. 2006;55(2):47–52. (In Russ.)
  14. Kramskaya TA, Leontyeva GF, Grabovskaya KB, et al. The analysis of protective activity of polyvalent group В streptococcal recombinant vaccine based on conserved surface proteins. Medicinskij alfavit. 2015;1(6):30–33. (In Russ.)
  15. Gupalova T, Leontieva G, Kramskaya T, et al. Development of experimental GBS vaccine for mucosal immunization. PLoS One. 2018;13(6):e0198577. doi: 10.1371/journal.pone.0198577
  16. Filimonova VYu, Dukhovlinov IV, Kramskaya TA, et al. Chimeric proteins based on the immunogenic epitopes of streptococcus surface pathogenicity factors as vaccines for group B streptococcal infections. Medicinskij akademicheskij zhurnal. 2016;16(3):82–89. (In Russ.). doi: 10.17816/MAJ16382-89
  17. Glaser P, Rusniok C, Buchrieser C, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Molecular Microbiology. 2002;45(6):1499–513. doi: 10.1046/j.1365-2958.2002.03126.x
  18. Tettelin H, Masignani V, Cieslewicz MJ, et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA. 2002;99(19):12391–12396. doi: 10.1073/pnas.182380799
  19. Brochet M, Couve E, Glaser P, et al. Integrative conjugative elements and related elements are major contributors to the genome diversity of Streptococcus agalactiae. J Bacteriol. 2008;190(20):6913–6917. doi: 10.1128/JB.00824-08
  20. Herbert MA, Beveridge CJE, McCormick D, et al. Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B Streptococcal strains. BMC Microbiology. 2005;5(31):1–13. doi: 10.1186/1471-2180-5-31
  21. Kuleshevich E, Ferretti J, Santos Sanches I, et al. Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII. Folia Microbiol (Praha). 2017;62(5):393–399. doi: 10.1007/s12223-017-0509-8
  22. Poyart C, Tazi A, Réglier-Poupet H, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol. 2007;45(6):1985–1988. doi: 10.1128/JCM.00159-07
  23. Kuleshevich EV, Savicheva AM, Arzhanova ON, et al. Distribution and genetic organization of pathogenicity island XII among the clinical strains of GBS. Molecular genetics, microbiology and virology. 2013;28(1):15–19. doi: 10.3103/S0891416813010023

补充文件

附件文件
动作
1. JATS XML
2. 图1 B组链球菌致病岛PAI-A和PAI-A1的结构。垂直线表示同源区域

下载 (209KB)
3. 图2 SspB1a:基因临床菌株聚合酶链反应产物的电泳图谱:1 - 菌株2978、2 - 菌株3093、3 - 菌株2828、 4 - 菌株3481、5 - 菌株3482、6 - 菌株2698、7 - 菌株3085、 8 - 菌株3030、9 - 阳性对照

下载 (13KB)

版权所有 © Kuleshevich E., Ilyasov Y., Linnik D., Malchenkova A., Arzhanova O., Briko N., Glushkova E., Priputnevich T., Suvorov A., 2021



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).